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Background: Our aim was to evaluate predictive factors of malignancy in patients with cytologically
suspicious for Hurthle cell neoplasm (HCN) of thyroid nodules.
Materials and methods: We searched cases with cytologically suspicious for HCN from 11,569 ultrasound-
guided ﬁne-needle aspirations (US-FNA) performed at our institution. Nodules that were conﬁrmed
surgically or followed-up for at least 2 years were compared with respect to age, gender, tumor size, US
diagnosis, and US ﬁndings to predict malignancy.
Results: The incidence of cases with cytologically suspicious for HCN was 1.2% (143 of 11,569). Of 75
nodules that underwent sufﬁcient follow-up or surgery, malignancies were found in 11 (14.7%). Malig-
nant histological examination revealed oncocytic variants of papillary thyroid carcinoma (PTC) in 3 cases,
classic PTC in 1, Hurthle cell carcinoma in 3, follicular carcinoma in 3 and an unclassiﬁed carcinoma in 1.
In univariate analysis, tumor size was signiﬁcantly larger in malignant nodules compared to benign
nodules (p ¼ 0.026). The best cut-off value of tumor size in predicting malignancy was 2.5 cm. (p ¼ 0.006,
sensitivity: 63.6%, speciﬁcity: 79.7%). The incidences of hypoechogenicity and malignant US diagnoses
were higher in malignant nodules than in benign nodules (p < 0.001). In multivariate analysis, tumor size
was an independent factor in predicting malignancies. (p ¼ 0.037, odd ratio: 2.09, conﬁdence interval:
1.046e4.161).
Conclusion: Preoperative US provides predictive factors of malignancy in thyroid nodules with cyto-
logically suspicious for HCN. Predictive factors include tumor size of 2.5 cm or greater, hypoechoic nodule
and malignant US diagnosis.
 2013 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Hurthle cell neoplasm (HCN) of the thyroid gland is a relatively
rare tumor of follicular cell origin that is composed either pre-
dominantly or entirely of large and polygonal cells with oxyphilic
features.1 The incidence of HCN varies from 3% to 10% of all thyroid
nodules.2 Hurthle cell carcinoma (HCC) of the thyroid gland rep-
resents approximately 3% of all differentiated thyroid cancers. HCC
is deemed to behave more aggressively compared to other well-
differentiated thyroid cancers, resulting in the higher incidence of: þ82 2 3410 0084.
anmail.net (J.H. Shin).
ciates Ltd. Published by Elsevier Ltmetastasis, lower survival rate and less responsiveness to iodine
therapy.2,3 Preoperative estimation of cytologically suspicious for
HCN may affect surgeons’ decisions in terms of the extent of the
operation and may reduce the rate of re-operation due to a
malignancy.
Ultrasound (US)-guided ﬁne needle aspiration (FNA) is widely
considered a standard method for diagnosing thyroid nodules
with indeterminate or suspicious malignant ﬁndings detected on
US. However, the cytological analysis in terms of HCN restricts
distinguishing benign from malignant lesions.4,5 Based on insti-
tutional experiences, frozen section examination of HCN has
variable diagnostic value in determining malignancy during sur-
gery.5 The ﬁnal diagnosis of HCN is obtained only on deﬁnite
histology in which HCC and follicular carcinoma reveal capsulard. All rights reserved.
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ORIGINAL RESEARCHand/or vascular invasion.2,5 Approximately 5%e35% of HCN diag-
nosed by cytology may be found to harbor malignancy by ﬁnal
histological assessment.6 Therefore, the inability to preoperatively
diagnose accurately the small subset of patients harboring ma-
lignancies can result in majority of patients undergoing poten-
tially unnecessary operations with associated complications and
morbidity.7
It was investigated to be associated with malignant HCN that
patients had clinical and cytological predictive factors, such as male
gender, old age, large size in the nodules and some cytological
features of nuclear clouding, small cell dysplasia and large cell
dysplasia.4,8,9 Previous reports have produced inconsistent results
with utilizing these factors.10,11 Preoperative radiological impres-
sion facilitates increasing the accuracy of cytology and frozen sec-
tion examination. With the advanced technology of US and widely
accepted US criteria, we evaluated predictive factors of malignancy
in patients with cytologically suspicious for Hurthle cell neoplasm
(HCN) of thyroid nodules.
2. Materials and methods
2.1. Patients
This retrospective studywas approved by our International Review Board, with a
waiver of informed consent. Between Jan 2007 and Dec 2008, 11,569 US-guided FNAHCN: Hurthle cell neoplasm, PTC: papillary thyroid ca
thyroid cancer, HCC: Hurthle cell carcinoma, FTC: foll
FA: follicular adenoma, HCA: Hurthle cell adenoma
11569 US-FNA examinations for 
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Fig. 1. Flow chart oof thyroid nodules were performed at our institution. We retrospectively reviewed
cases with cytologically suspicious for HCN on cytology. Ultimately, 75 patients who
underwent surgical resection or clinical and radiological follow up for more than 2
years were enrolled for statistical analysis. We evaluated age and gender of the
patients and tumor size as clinical predictive factors for malignant nodules.
2.2. US and US-FNA
US was performed using high-resolution US equipment (IU22; Philips Medical
Systems, Bothell, WA or HDI 5000; Advanced Technology Laboratories, Bothell, WA)
with 5e12 MHz linear array transducers. US examination included the evaluation of
the entire thyroid gland and lateral neck compartments. US examination was per-
formed by one of seven radiologists. We evaluated morphologic ﬁndings and
diagnosis of thyroid nodules on US as follows: size (the maximum diameter as
measured); shapee oval to round or not oval to round; margine smooth, spiculated
or ill-deﬁned; orientation e wider than tall or taller than wide; echogenicity e
hyper-echoic, iso-echoic or hypo-echoic; cystic change e none or present and
calciﬁcation e none or present. The diagnoses of all thyroid nodules were pro-
spectively categorized as suspicious for malignancy or probably benign by two ra-
diologists with an experience of 9 years and 4 years, respectively. The inclusion
criteria of suspicious for malignant ﬁnding in a thyroid nodule were as follows: not
oval to round shape, spiculated margin, taller than wide orientation, hypo-
echogenicity, and the presence of macrocalciﬁcation or microcalciﬁcation.12 Prob-
able benign diagnoses were attributed to thyroid nodules that were negative for
malignant features.
US-FNA was followed by diagnostic US. Using freehand technique and direct US
visualization, a 23-gauge needle tip was placed in the targeted lesion, below the
center of the transducer and was advanced to the lesion along the image plane. The
aspirated materials were placed on appropriately labeled glass slides and, smearedncer, OV PTC: oncocytic variant of papillary 
icular thyroid cancer, NH: nodular hyperplasia, 
thyroid nodules from 
2008
suspicious for HCN 
3
68 patients with no surgery or 
follow up less than 2 years 
were excluded.
NA with follow up more than 2 years 
)
enign (n=32)
NH: 30
f population.
Fig. 2. A 55 year-old male suspicious for Hurthle cell neoplasm on cytology. On US, a
4.5 cm circumscribed hypo-echoic mass is seen in right thyroid lobe. US diagnosis was
suspicious for malignancy. Histology revealed follicular thyroid carcinoma. (a: trans-
verse image, b: longitudinal image).
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rinsed with ethyl alcohol for processing as a cell block. The slides were sent to the
pathology department for analysis.
2.3. Cytopathologic evaluation
Cytological diagnosis of HCN was performed by one of six cytopathologists. The
FNA specimen was considered adequate when at least 6 groups of well-preserved
follicular cells on different slides were collected with each group including at least
10 follicular cells. The cytological criteria used for the diagnosis of HCN included
cellular specimen, monotonous population of Hurthle cells or oncocytic cells (more
than 75% of FNA specimen) with scant or no colloid materials and absence of nuclear
features of papillary thyroid cancers.13,14 The Bethesda system for reporting thyroid
cytopathology had not been introduced in our institution at the time of the study.
2.4. Statistical analysis
The statistical analysis was performed using the SAS 9.3 (SAS institute Inc., Cary,
NC, USA). The two-sample t test and ManneWhitney test was applied to compare
clinical factors between benign and malignant lesions. The tumor size receiver
operating characteristic curve was developed using R 2.15.1(a language and envi-
ronment for statistical computing. 2012 The R Foundation for Statistical Computing,
Vienna, Austria). The best cut-off value of tumor size to predict malignancy was
chosen using Youden’s Index, which maximizes the sum of the sensitivity
plus speciﬁcity. Fisher exact test in univariate and multivariate logistic regression
analysis was applied to clinical and radiologic factors between the benign and
malignant nodules with cytologically suspicious for HCN. P values < 0.05 were
considered statistically signiﬁcant. Numeric data were expressed as mean  stan-
dard deviation (SD).
3. Results
The incidence of cytologically suspicious features for HCN in
thyroid nodules was 1.2% (143 of 11,569 US-FNA examinations).
(Fig. 1) Of the 143 patients, 68 patients who did not undergo either
surgery or the follow up period of more than 2 years were excluded.
Finally, 75 patients with 75 thyroid nodules were enrolled for the
statistical analysis in this study. Of 75 patients, 43 (57.3%) patients
underwent surgery. The remaining 32 patients had a follow up of
more than 2 years (mean: 41.1 months, range: 24e54 months) and
a repeat FNA following the initial FNA. All 32 thyroid nodules in 32
patients revealed no interval change at US follow-up. Of the 75
nodules with cytologically suspicious for HCN, 11 cases (14.7%)
were malignant; 3 cases (3.9%) were oncocytic variants of papillary
thyroid carcinoma (PTC), 1 case (1.3%) was classic PTC, 3 cases 3
(3.9%) were HCC, 3 (3.9%) were follicular thyroid carcinoma, 1 case
(1.3%) was an unclassiﬁed cancer, 64 cases (85.3%) were benign
thyroid nodules, 57 cases (76%) were nodular hyperplasia, 3 cases
(4%) were Hurthle cell adenoma, 2 (2.7%) were follicular adenoma,1
case (1.3%) was lymphocytic thyroiditis and one case (1.3%) was a
parathyroid adenoma.
In the univariate analysis shown in Table 1, tumor sizes of ma-
lignant nodules (2.63 cm  1.44, range: 0.6e5) were signiﬁcantly
larger than that of benign nodules (1.65 cm  0.982, range: 0.4e4)
(p value ¼ 0.026). The best cut off value of tumor size in order to
differentiate malignant nodules from benign nodules was 2.5 cm (p
value ¼ 0.006). Using the cut off value of 2.5 cm, the diagnostic
performance was as follows; sensitivity: 63.6%; speciﬁcity: 79.7%;
positive predictive value: 35% and negative predictive value: 92.7%.
With the US ﬁndings, malignant nodules were more frequently
hypo-echoic compared to benign nodules (Figs. 2 and 3). (p¼ 0.011)
US diagnosis was statistically signiﬁcant in terms of diagnosing
malignant lesions from benign lesions of HCN. (p < 0.001) Gender
and age of patients were not signiﬁcantly different between benign
and malignant nodules. Orientation, shape, margin, presence of
calciﬁcation and cystic change of thyroid nodules were not signif-
icantly different between two groups. In multivariate analysis as
shown in Table 2, tumor size was an independent factor in pre-
dicting malignancies (p ¼ 0.037, odd ratio: 2.09, conﬁdence inter-
val: 1.046e4.161).4. Discussion
The majority of recent surgical studies have revealed that the
incidence of malignant HCN ranges from 5% to 35%.6,15 Some au-
thors have suggested that 80% or more of HCNs in the thyroid gland
are benign especially when studies include Hurthle cell adenoma-
tous nodules found in the context of goiter and chronic lymphocytic
thyroiditis.16e18 The present study revealed concordant results. The
incidence of malignancy was 25.6% (11/43 patients) among the
patients who underwent surgery.
The inability todifferentiate amalignant lesionofHCNon thebasis
of cytology has resulted in a general recommendation that patients
with cytologically suspicious for HCN undergo surgical resection.7,19
Moreover, intra-operative frozen section is not helpful in the diag-
nosis of follicular carcinoma and HCC since they depended on the
presence of vascular and/or capsular invasion which is occasionally
not identiﬁed on the frozen section.20 Therefore, if preoperative US
ﬁndings can serve as a clinical predictive factor, it may help guide
surgeons in order to determining accurate results in decisions
regarding the extent of the surgery. The inability of preoperative ac-
curate diagnosis forHCN facilitates theneed for avarietyof diagnostic
methods and the summation of these methods in order to enhance
conﬁdence with respect to the extent of surgical involvement.
Many authors have suggested variable clinical predictive factors
for malignancies in thyroid lesions diagnosed as cytologically
Table 1
Comparison of clinical factors, US ﬁndings and US diagnosis in thyroid nodules with
cytologically suspicious for HCN by univariate analyses.
Final results Benign (n ¼ 64) Malignant (n ¼ 11) p Value
Gender (M:F) 17:47 3:8 1.000
Age 51.76  10.87
(range: 32e77)
52.27  15.33
(range: 26e76)
0.894
Size (cm) 1.65  0.982
(range: 0.4e4)
2.63  1.44
(range: 0.6e5)
<2.5 cm 51(80%) 4(36.4%) 0.026
 2.5 cm 13(20%) 7(63.6%)
US ﬁndings
Shape
Oval to round 63 (98.5%) 11 (100%) 1.000
Not oval to round 1 (1.5%) 0
Margin
Smooth 58 (90.1%) 11 (100%) 1.000
Spiculated 2 (3.7%) 0
Ill deﬁned 4 (6.2%) 0
Orientation
Wider than tall 62 (96.9%) 11 (100%) 1.000
Taller than wide 2 (3.1%) 0
Echogenicity
Iso-echoic 38 (59.3%) 2 (18.2%) 0.011
Hypo-echoic 26 (40.7%) 9 (81.8%)
Calciﬁcation
None 48 (75%) 9 (81.8%) 1.000
Present 16 (25%) 2 (18.2%)
Cystic change
None 48 (75%) 9 (81.8%) 1.000
Present 16 (25%) 2 (18.2%)
US diagnosis <0.001
Benign 49 (75.4%) 2 (18.2%)
Malignant 15 (24.6%) 9 (81.8%)
The bold values indicate statistically signiﬁcant p-values.
Table 2
Multivariate analyses of thyroid nodules with cytologically suspicious for HCN in
predicting malignancies.
Factors Odd ratio p Value Conﬁdence interval
Gender 1.070 0.941 0.181e6.323
Age 0.970 0.373 0.907e1.037
Tumor size 2.087 0.037 1.046e4.161
US ﬁndings
Echogenicity 1.533 0.775 0.082e28.554
Calciﬁcation 0.357 0.334 0.044e2.886
Cystic change 1.223 0.854 0.143e10.494
US diagnosis 13.001 0.073 0.785e215.428
The bold values indicate statistically signiﬁcant p-values.
Fig. 3. A 44 year-old male suspicious for Hurthle cell neoplasm on cytology. On US, a
4 cm circumscribed iso-echoic mass without presence of calciﬁcation and cystic
change is seen in the right thyroid lobe. US diagnosis was probably benign. Histology
revealed follicular adenoma. (a: transverse image, b: longitudinal image).
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Thyroid function test was generally not estimated as a predictive
factor.6,21e23 Few studies have focused on US ﬁndings for HCN in
the literature.8,24 Kim et al. reported that suspicious malignant US
ﬁndings such as hypo-echogenicity, irregular margin and calciﬁ-
cation were not predictive factors.8 A type of follicular thyroid
carcinoma was differentiated from papillary thyroid carcinoma in
terms of its US features.10 Therefore, preoperative diagnosis using
the previously reported US ﬁndings of malignant thyroid nodules
may reveal a signiﬁcant limitation in predicting follicular carci-
nomas preoperatively. In the present study, hypo-echogenicity of
US ﬁndings was the only parameter that had a signiﬁcant difference
between benign and malignant nodules, although the signiﬁcance
was not consistent in the multivariate analysis. Furthermore, US
diagnosis integrated from each US ﬁnding aided in predicting ma-
lignant lesions. A major strength of this study is to achieve US
differentiation of nodules with cytologically suspicious for HCN in
the larger population.
Larger tumor size of HCN is widely known as the most powerful
predictive factor. The cut off value of the tumor size is variable
ranging from 1.5 cm to 4 cm.1,2,5,8 However, other studies have
reported that the tumor size of HCN is not signiﬁcantly differentbetween benign and malignant lesions.13,25 In the present study,
the tumor size of malignant nodules was signiﬁcantly larger than
that of benign nodules in both univariate andmultivariate analyses.
Furthermore, a tumor size of 2.5 cm or greater was a unique in-
dependent factor in differentiating malignancies. Of the 11 malig-
nant nodules, seven (63.6%) were larger than 2.5 cm. We suggest
that surgeons initially consider a lobectomy for nodules
with cytologically suspicious for HCN and a size less than 2.5 cm,
owing to the high sensitivity and speciﬁcity of size in predicting
malignancies.
Some investigators have suggested that patients with cytologi-
cally suspicious for HCN should initially undergo lobectomy fol-
lowed by complete thyroidectomy, if a diagnosis of cancer is
rendered on histologic conﬁrmation.1 Other groups have claimed
that all HCNs should be regarded as malignancies and treated
aggressively with total thyroidectomy since HCC has a worse
prognosis than other follicular carcinomas.1,26 US diagnosis of HCN
was benign with a 75.4% concordant rate in the present study. We
suggest that lobectomy is recommended as an initial surgery for
nodules with benign US features.
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present study. The proportion of females was much higher than
males in both benign and malignant lesions. There was no statis-
tical difference in gender as a predictive factor for malignant thy-
roid lesions as compared with other studies.20,22,27 The patients
with malignant lesions of HCN were statistically older in compar-
ison to those with benign lesions; similar to ﬁndings reported in
several previous studies.5,21,28 Lopez-Penabad et al. stated that the
average age of patients with malignant HCN was 8.7 years older
than those with benign lesions28 although other investigators have
not found the same association.22,29
There were several limitations in the current study. First, the
study was a retrospective analysis with a smaller population
compared to other cohort studies.1,5,8 However, the present study
was focused on detailed US ﬁndings and US diagnosis. Only cases of
cytologically suspicious features for HCN were included in the
population and patients in the study had more sufﬁcient clinical
and radiologic follow up periods in comparison to previous
studies.8,13 Since all patients with HCN did not undergo surgery,
histological conﬁrmation was not available for all patients. How-
ever, this problem was unavoidable due to the rarity of the disease
and was compensated with a sufﬁcient follow-up period.
In conclusion, preoperative US provides predictive factors of
malignancy in thyroid nodules with cytologically suspicious fea-
tures for HCN. Predictive factors include a tumor size of 2.5 cm or
greater, a hypoechoic nodule and malignant US diagnosis. Preop-
erative estimation of these nodules may affect surgeons’ decisions
in terms of the extent of surgery and may help to reduce the rate of
potentially unnecessary surgeries.
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